Search Results

There are 27926 results for: content related to: Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer

  1. You have free access to this content
    Patient preferences in advanced or recurrent ovarian cancer

    Cancer

    Volume 120, Issue 23, December 1, 2014, Pages: 3651–3659, Laura J. Havrilesky, Angeles Alvarez Secord, Jessie A. Ehrisman, Andrew Berchuck, Fidel A. Valea, Paula S. Lee, Stephanie L. Gaillard, Greg P. Samsa, David Cella, Kevin P. Weinfurt, Amy P. Abernethy and Shelby D. Reed

    Version of Record online : 4 AUG 2014, DOI: 10.1002/cncr.28940

  2. You have free access to this content
    Which is the best foot to put forward in recurrent ovarian cancer?

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3229–3231, Peter G. Rose

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26615

  3. THE BIASES OF FEDERAL RESERVE BANK PRESIDENTS

    Economic Inquiry

    Volume 33, Issue 2, April 1995, Pages: 274–284, THOMAS HAVRILESKY and JOHN GILDEA

    Version of Record online : 28 SEP 2007, DOI: 10.1111/j.1465-7295.1995.tb01862.x

  4. You have free access to this content
    A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3283–3293, Angeles Alvarez Secord, Andrew Berchuck, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, Larry E. Puls, Robert W. Holloway, George S. Lewandowski, Fidel A. Valea and Laura J. Havrilesky

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26610

  5. Recurrent ovarian cancer: Treatment with pegylated liposomal doxorubicin; a Westmead Cancer Care Centre experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 6, Issue 1, March 2010, Pages: 66–73, Rachel F DEAR, Bo GAO and Paul HARNETT

    Version of Record online : 26 JAN 2010, DOI: 10.1111/j.1743-7563.2009.01263.x

  6. You have free access to this content
    Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer

    Cancer

    Volume 118, Issue 9, 1 May 2012, Pages: 2403–2410, Martee L. Hensley, Sara Kravetz, Xiaoyu Jia, Alexia Iasonos, William Tew, Lauren Pereira, Paul Sabbatini, Christin Whalen, Carol A. Aghajanian, Corinne Zarwan and Suzanne Berlin

    Version of Record online : 20 SEP 2011, DOI: 10.1002/cncr.26569

  7. OUTSIDE INFLUENCES ON MONETARY POLICY: A SUMMARY OF RECENT FINDINGS

    Contemporary Economic Policy

    Volume 12, Issue 1, January 1994, Pages: 46–51, THOMAS HAVRILESKY

    Version of Record online : 2 JUL 2007, DOI: 10.1111/j.1465-7287.1994.tb00411.x

  8. SCREENING FOMC MEMBERS FOR THEIR BIASES AND DEPENDABILITY

    Economics & Politics

    Volume 3, Issue 2, July 1991, Pages: 139–149, Thomas Havrilesky and John Gildea

    Version of Record online : 27 OCT 2006, DOI: 10.1111/j.1468-0343.1991.tb00043.x

  9. Abstracts

    International Journal of Gynecological Cancer

    Volume 14, Issue s1, September 2004, Pages: 1–249,

    Version of Record online : 13 SEP 2004, DOI: 10.1111/j.1525-1438.2004.1315431.x

  10. Is combination chemotherapy superior to single-agent chemotherapy in second-line treatment?

    International Journal of Gynecological Cancer

    Volume 13, Issue s2, November 2003, Pages: 185–191, A. González-Martín

    Version of Record online : 18 DEC 2003, DOI: 10.1111/j.1525-1438.2003.13361.x

  11. Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

    Journal of Surgical Oncology

    Volume 72, Issue 3, November 1999, Pages: 162–169, Sharad A. Ghamande and M. Steven Piver

    Version of Record online : 15 NOV 1999, DOI: 10.1002/(SICI)1096-9098(199911)72:3<162::AID-JSO9>3.0.CO;2-0

  12. DISTRIBUTIVE CONFLICT AND MONETARY POLICY

    Contemporary Economic Policy

    Volume 8, Issue 2, April 1990, Pages: 50–61, THOMAS HAVRILESKY

    Version of Record online : 2 JUL 2007, DOI: 10.1111/j.1465-7287.1990.tb00590.x

  13. Positron emission tomography application for gynecologic tumors

    International Journal of Gynecological Cancer

    Volume 15, Issue 5, September 2005, Pages: 701–709, Y. NAKAMOTO, T. SAGA and S. FUJII

    Version of Record online : 12 SEP 2005, DOI: 10.1111/j.1525-1438.2005.00245.x

  14. Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 68–73, J. DUPONT, C. AGHAJANIAN, G. ANDREA, M. LOVEGREN, S. CHUAI, E. VENKATRAMAN, M. HENSLEY, S. ANDERSON, D. SPRIGGS and P. SABBATINI

    Version of Record online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00467.x

  15. Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives

    International Journal of Gynecological Cancer

    Volume 15, Issue 6, November 2005, Pages: 1002–1013, D. LORUSSO, G. FERRANDINA, E. FRUSCELLA, L. MARINI, V. ADAMO and G. SCAMBIA

    Version of Record online : 17 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00331.x

  16. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

    Intervention Review

    The Cochrane Library

    Khadra Galaal, Raj Naik, Robert E Bristow, Amit Patel, Andrew Bryant and Heather O Dickinson

    Published Online : 16 JUN 2010, DOI: 10.1002/14651858.CD007822.pub2

  17. Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer

    Cancer

    Volume 122, Issue 21, November 1, 2016, Pages: 3297–3306, Marcela G. del Carmen, Jeff G. Supko, Nora K. Horick, J. Alejandro Rauh-Hain, Rachel M. Clark, Susana M. Campos, Carolyn N. Krasner, Tina Atkinson and Michael J. Birrer

    Version of Record online : 15 JUL 2016, DOI: 10.1002/cncr.30196

  18. Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?

    Cancer

    Volume 123, Issue 18, September 15, 2017, Pages: 3450–3459, Federica Tomao, Maurizio D'Incalci, Elena Biagioli, Fedro A. Peccatori and Nicoletta Colombo

    Version of Record online : 5 JUL 2017, DOI: 10.1002/cncr.30830

  19. You have free access to this content
    Recent progress in the diagnosis and treatment of ovarian cancer

    CA: A Cancer Journal for Clinicians

    Volume 61, Issue 3, May/June 2011, Pages: 183–203, Danijela Jelovac and Deborah K. Armstrong

    Version of Record online : 27 APR 2011, DOI: 10.3322/caac.20113

  20. A phase II, multicenter trial of weekly topotecan in patients with recurrent platinum-sensitive epithelial cancers of the ovary and peritoneum

    International Journal of Gynecological Cancer

    Volume 18, Issue 2, March/April 2008, Pages: 249–254, J.V. BROWN III, M.A. RETTENMAIER, K.L. LOPEZ, C. GRAHAM, J.P. MICHA and B. GOLDSTEIN

    Version of Record online : 20 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01001.x